0001415889-19-001066.txt : 20190919 0001415889-19-001066.hdr.sgml : 20190919 20190919160515 ACCESSION NUMBER: 0001415889-19-001066 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190918 FILED AS OF DATE: 20190919 DATE AS OF CHANGE: 20190919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Curran Terrie CENTRAL INDEX KEY: 0001690298 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 191101817 MAIL ADDRESS: STREET 1: C/O MYOVANT SCIENCES INC. STREET 2: 320 WEST 37TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-09192019_040901.xml X0306 4 2019-09-18 0000816284 CELGENE CORP /DE/ CELG 0001690298 Curran Terrie C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 false true false false SEE REMARKS Common Stock 2019-09-18 4 M 0 4500 58.33 A 13493 D Common Stock 2019-09-18 4 S 0 4500 98.20 D 8993 D Common Stock 2019-09-18 4 S 0 6838 98.31 D 2155 D Common Stock 926 I 401(k) Plan Stock Option (right to buy) 58.33 2019-09-18 4 M 0 4500 0 D 2023-05-01 Common Stock 4500 2072 D The option was fully exercisable. The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the Company's 2008 Stock Incentive Plan). PRESIDENT, GLOBAL INFLAMMATION AND IMMUNOLOGY /s/ Jonathan Biller, Attorney-in-Fact 2019-09-19